Director/PDMR Shareholding

RNS Number : 9173M

GlaxoSmithKline PLC

21 July 2014

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors and Persons Discharging Managerial Responsibility (PDMR) on 21 July 2014 of the following increases in their notional interests in Ordinary Shares at a price of 1572.00 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $54.40 per ADS following the notional re-investment of the dividend paid to shareholders on 10 July 2014.

Director/PDMR	Ordinary Shares	ADSs
Sir Andrew Witty	16,496.396
Dr M M Slaoui		4,716.361
Mr S Dingemans	6,928.786
Mr S M Bicknell	1,118.001
Mr R G Connor	2,265.967
Mrs D P Connelly		1,961.322
Mr J Ford		253.675
Mr S A Hussain	5,620.681
Mr W C Louv		1,383.528
Mr D S Redfern	2,386.006
Ms C Thomas	3,293.059
Mr P C Thomson	1,606.307
Mr D E Troy		2,803.015
Dr P J T Vallance	6,860.558
Ms E Walmsley	3,988.143
Mrs V A Whyte	456.597

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

21 July 2014

 

END

 

 

RDSQFLFLZDFXBBD